Diagnostic Consumables Market: By Technology Type:, By Sample Type:, By Disease Indication:, By Segment Type: and Region Forecast 2020-2031
Report ID:61594
Published Date:Oct 2025
No of Pages:225
Format:
Diagnostic Consumables Market size was valued at US$ 203.33 billion in 2024 and is expected to reach US$ 291.88 billion by 2031, growing at a significant CAGR of 5.3% from 2025-2031. Diagnostic consumables, the essential tools that power medical testing, are a thriving segment within the healthcare industry. These single-use items, including test kits, reagents, pipettes, and petri dishes, play a critical role in diagnosing a wide range of diseases, from common infections to complex chronic conditions. As the demand for accurate and efficient diagnostics continues to surge, the market is experiencing significant growth.
In addition, the innovation in the medical field is constantly pushing the boundaries of diagnostics. Emerging technologies like personalized medicine and molecular diagnostics require highly specific consumables. Personalized medicine tailors treatments to an individual's unique genetic makeup, necessitating specialized tests and their accompanying consumables. Similarly, molecular diagnostics offer highly detailed insights into diseases at the molecular level, requiring specialized kits and reagents. These advancements not only improve diagnosis accuracy but also create new market segments within the diagnostic consumables space.
Moreover, the rise of automation in diagnostic laboratories marks another significant driver for the market. Automated systems offer increased efficiency and accuracy, but they also necessitate specific consumables designed for smooth integration within the automated workflow. This shift towards automation creates a demand for specialized consumables that are compatible with these systems. However, the market is heavily regulated to ensure quality and safety. Stringent regulatory processes for approval and licensing can create delays in bringing new and innovative consumables to market. Additionally, navigating this complex regulatory landscape can be expensive for manufacturers, further hindering market growth.
Study Period
2025-2031Base Year
2024CAGR
5.3%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
A significant factor influencing the market is the global demographic shift towards an aging population. Individuals are more susceptible to chronic diseases like diabetes, heart ailments, and cancer. This translates to a heightened need for regular diagnostic testing, fueling the demand for consumables required for those tests. In addition, the healthcare landscape is witnessing a paradigm shift towards preventive care and early disease detection. This proactive approach emphasizes regular check-ups and diagnostic screenings. Early detection allows for timely interventions and better treatment outcomes, all of which rely heavily on diagnostic consumables. This shift from reactive to preventive healthcare creates a thriving market for these essential tools.
Furthermore, globally, healthcare expenditure is on the rise. This includes increased funding for diagnostic services and the adoption of new diagnostic technologies. As healthcare budgets grow, so too does the availability of resources for acquiring diagnostic consumables. This trend translates to a larger market for these essential tools.
Based on regions, the market share is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA. Currently, North America holds the dominating position in the market. North America boasts a well-developed healthcare system with a high concentration of hospitals, diagnostic laboratories, and research institutions. This extensive infrastructure necessitates a constant supply of diagnostic consumables to support a large volume of medical testing. In addition, the region benefits from significant investments in healthcare, which translates into a willingness to adopt new diagnostic technologies and their associated consumables.
Moreover, there's a growing emphasis on preventive care and early disease detection in the region. This focus fuels the demand for diagnostic tests, and consequently, the consumables required to perform them. The Asia Pacific region is rapidly emerging as a force to be reckoned with in the market. This growth is propelled by several key drivers such as the aging population, government initiatives, rising disposable incomes, and focus on point-of-care testing.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 203.33 billion |
|
Market Size in 2031 |
US$ 291.88 billion |
|
Market CAGR |
5.3% |
|
By Technology Type |
|
|
By Sample Type |
|
|
By Diseases Indication |
|
|
By Segment Type |
|
|
By Region |
|
Download Free Sample Report
The diagnostic consumables market size was valued at US$ 203.33 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2031.
The North America region is dominating the market.
The leading players in the market are Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott, Sarstedt AG Co.KG, Thermo Fisher Scientific, Johnson & Johnson, Becton, Dickinson and Company, Bio-Rad Laboratories, Sysmex Corporation, and bioMerieux.
Content Updated Date: Jan 2026
| 1.Executive Summary |
| 2.Global Diagnostic Consumables Market Introduction |
| 2.1.Global Diagnostic Consumables Market - Taxonomy |
| 2.2.Global Diagnostic Consumables Market - Definitions |
| 2.2.1.Technology Type |
| 2.2.2.Sample Type |
| 2.2.3.Diseases Indication |
| 2.2.4.Segment Type |
| 2.2.5.Region |
| 3.Global Diagnostic Consumables Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Diagnostic Consumables Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Diagnostic Consumables Market By Technology Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Immunoassay |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Molecular Assay |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Clinical Chemistry |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Heamatology |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. NGS |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Diagnostic Consumables Market By Sample Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Blood/Plasma |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Urine |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Saliva |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Diagnostic Consumables Market By Diseases Indication, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Infectious Diseases |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Respiratory Diseases |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. STD's |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Cancer |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Digestive Infections |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Genetic Diseases |
| 7.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8.Global Diagnostic Consumables Market By Segment Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Public |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Private |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.Global Diagnostic Consumables Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Diagnostic Consumables Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Technology Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Immunoassay |
| 10.1.2.Molecular Assay |
| 10.1.3.Clinical Chemistry |
| 10.1.4.Heamatology |
| 10.1.5.NGS |
| 10.1.6.Others |
| 10.2. Sample Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Blood/Plasma |
| 10.2.2.Urine |
| 10.2.3.Saliva |
| 10.2.4.Others |
| 10.3. Diseases Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Infectious Diseases |
| 10.3.2.Respiratory Diseases |
| 10.3.3.STD's |
| 10.3.4.Cancer |
| 10.3.5.Digestive Infections |
| 10.3.6.Genetic Diseases |
| 10.3.7.Others |
| 10.4. Segment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Public |
| 10.4.2.Private |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Diagnostic Consumables Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Technology Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Immunoassay |
| 11.1.2.Molecular Assay |
| 11.1.3.Clinical Chemistry |
| 11.1.4.Heamatology |
| 11.1.5.NGS |
| 11.1.6.Others |
| 11.2. Sample Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Blood/Plasma |
| 11.2.2.Urine |
| 11.2.3.Saliva |
| 11.2.4.Others |
| 11.3. Diseases Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Infectious Diseases |
| 11.3.2.Respiratory Diseases |
| 11.3.3.STD's |
| 11.3.4.Cancer |
| 11.3.5.Digestive Infections |
| 11.3.6.Genetic Diseases |
| 11.3.7.Others |
| 11.4. Segment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Public |
| 11.4.2.Private |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Diagnostic Consumables Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Technology Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Immunoassay |
| 12.1.2.Molecular Assay |
| 12.1.3.Clinical Chemistry |
| 12.1.4.Heamatology |
| 12.1.5.NGS |
| 12.1.6.Others |
| 12.2. Sample Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Blood/Plasma |
| 12.2.2.Urine |
| 12.2.3.Saliva |
| 12.2.4.Others |
| 12.3. Diseases Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Infectious Diseases |
| 12.3.2.Respiratory Diseases |
| 12.3.3.STD's |
| 12.3.4.Cancer |
| 12.3.5.Digestive Infections |
| 12.3.6.Genetic Diseases |
| 12.3.7.Others |
| 12.4. Segment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Public |
| 12.4.2.Private |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Diagnostic Consumables Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Technology Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Immunoassay |
| 13.1.2.Molecular Assay |
| 13.1.3.Clinical Chemistry |
| 13.1.4.Heamatology |
| 13.1.5.NGS |
| 13.1.6.Others |
| 13.2. Sample Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Blood/Plasma |
| 13.2.2.Urine |
| 13.2.3.Saliva |
| 13.2.4.Others |
| 13.3. Diseases Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Infectious Diseases |
| 13.3.2.Respiratory Diseases |
| 13.3.3.STD's |
| 13.3.4.Cancer |
| 13.3.5.Digestive Infections |
| 13.3.6.Genetic Diseases |
| 13.3.7.Others |
| 13.4. Segment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Public |
| 13.4.2.Private |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Diagnostic Consumables Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Technology Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Immunoassay |
| 14.1.2.Molecular Assay |
| 14.1.3.Clinical Chemistry |
| 14.1.4.Heamatology |
| 14.1.5.NGS |
| 14.1.6.Others |
| 14.2. Sample Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Blood/Plasma |
| 14.2.2.Urine |
| 14.2.3.Saliva |
| 14.2.4.Others |
| 14.3. Diseases Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Infectious Diseases |
| 14.3.2.Respiratory Diseases |
| 14.3.3.STD's |
| 14.3.4.Cancer |
| 14.3.5.Digestive Infections |
| 14.3.6.Genetic Diseases |
| 14.3.7.Others |
| 14.4. Segment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Public |
| 14.4.2.Private |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Roche Diagnostics |
| 15.2.2.Siemens Healthineers |
| 15.2.3.Danaher Corporation |
| 15.2.4.Abbott |
| 15.2.5.Sarstedt AG Co.KG |
| 15.2.6.Thermo Fisher Scientific |
| 15.2.7.Johnson & Johnson |
| 15.2.8.Becton, Dickinson and Company |
| 15.2.9.Bio-Rad Laboratories |
| 15.2.10.Sysmex Corporation |
| 15.2.11.bioMerieux |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
